phase 3 clinical trial – Patient Worthy

Targeted Immunomodulation Transforms Dermatomyositis Management: Phase 3 Brepocitinib Trial Demonstrates Significant Clinical Benefits

Post author:Bree Clare
Post published:April 16, 2026
Post category:Dermatomyositis

Researchers have demonstrated substantial therapeutic benefits for brepocitinib, an oral tyrosine kinase 2/Janus kinase 1 inhibitor, in adults with dermatomyositis, according to findings from a Phase 3 clinical trial published…

source: shutterstock.com

These Clinical Trials Could be Game Changers in the Latter Half of 2023

Post author:James Moore
Post published:July 14, 2023
Post category:Duchenne Muscular Dystrophy Familial Hypercholesterolemia Heterozygous Familial Hypercholesterolemia Multiple Sclerosis Phase 3 clinical trial Phase III Trial Transthyretin amyloid cardiomyopathy

In a story from BioPharma Dive, a number of high-profile clinical trials are under way that could see conclusive results by the end of 2023. While some of these are…

source: unsplash.com

Enrollment Completes for Phase 3 Thyroid Eye Disease Trial in Japan

Post author:James Moore
Post published:December 8, 2022
Post category:Phase 3 clinical trial Thyroid eye disease

According to a story from morningstar.com, the pharmaceutical company Horizon Therapeutics plc recently announced the completion of enrollment for its phase 3 clinical trial in Japan. This trial is testing…

Targeted Immunomodulation Transforms Dermatomyositis Management: Phase 3 Brepocitinib Trial Demonstrates Significant Clinical Benefits

These Clinical Trials Could be Game Changers in the Latter Half of 2023

Enrollment Completes for Phase 3 Thyroid Eye Disease Trial in Japan

Let’s Work Together!

Keep Up to Date

Learn More